Fabienne Ricklin
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms, Cancer therapeutics and mechanisms, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial Properties(2011)68 cited
- → New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine(2004)55 cited
- → Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate(2010)40 cited
- → Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit(2009)38 cited
- → An aminomethylpyrimidine DPP-IV inhibitor with improved properties(2004)36 cited
- → Total Synthesis of Cyclothialidine(1996)15 cited
- → Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity(2010)13 cited
- → From the DNA Gyrase Inhibitor Cyclothialidine to a New Class of Antibacterial Agents(2003)1 cited
- → CCDC 797879: Experimental Crystal Structure Determination(2012)